Fujifilm plots $1.6B expansion at CDMO sites in Denmark and Texas, adding 450 jobs

SourceFierce Pharma
Date Published06/29/2022
Author Name Zoey Becker
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Fujifilm Diosynth Biotechnologies
Parent companyFUJIFILM Holdings Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):450
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Capital investment ($):1.6
Country(ies) from which reshored:Japan
State(s) reshored to:TX
If relevant, work nearshored to:-
Product(s) reshoredcell culture
What non-domestic negative factors made offshoring less attractive?Green considerations
Find Reshoring Articles